MMP9 and triple-A syndrome: PPARα activation reduces AAA incidence in ApoE−/− and LDLR−/− mice, by downregulating osteopontin, MMP-9, and resistin, limiting macrophage recruitment to the aortic wall and suppressing extracellular matrix remodeling.624